0.00010.00% ( 0.0000 )
Delay Delisted: Oct 27, 09:05:00 (EDT)Current ValuationThe current P/E ratio is 0.00, within the reasonable range, cheaper than 99.62% of the time in the past 1 years, and the industry ranks 15/44, the industry Median -0.31.
-0xP/E
--Stock price
-0xP/E
Stock price--
Historical Valuation
P/E ratioTypical rangeMedian
- P/E ratio
- 0.00x
- Typical range
- 0.00x–0.00x
Peer P/E ratio Comparison
It displays how the company's P/E ratio compares to top companies within its industry.
016324864
The industry median valuation is currently at or below 0 and may not serve as a meaningful benchmark.
Industry P/E ratio Comparison
This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.
0x30x60x90x120x150x
| Name/Symbol | |||
|---|---|---|---|
BLCOUSBausch + Lomb | -36.72x | 94.03% | $6.28B |
MMEDUSMiniMed | -16.72x | 151.04% | $5.25B |
NEOGUSNeogen | -47.51x | 216.68% | $2.67B |
ESTAUSEstablishment Labs | -50.41x | 30.98% | $1.96B |
XRAYUSDentsply Sirona | -3.37x | 112.97% | $1.84B |
KIDSUSOrthopediatrics | -15.79x | 29.08% | $627.16M |
CERSUSCerus | -70.41x | 56.25% | $477.61M |
SMTIUSSanara Medtech | -9.48x | 104.59% | $303.39M |
OSURUSOraSure Tech | -5.85x | 35.64% | $287.60M |
RXSTUSRxSight | -4.37x | 0.66% | $205.05M |
ZTEKFUSZENTEK LTD | -6.28x | -- | $47.09M |
TELAUSTela Bio | -1.07x | 15.66% | $44.06M |
XTNTUSXtant Med | -3.47x | 477.77% | $38.59M |
RMTIUSRockwell Medical | -5.39x | 32.67% | $28.21M |
NSPRUSInspireMD | -0.40x | -- | $20.92M |
RVPUSRetractable Tech | -4.83x | -- | $17.39M |
CUPRUSCuprina | -3.50x | -- | $12.61M |
LUCYUSInnovative Eyewear | -0.90x | -- | $6.89M |
TUTHUSStandard Dental Labs Inc. | -3.17x | -- | $3.46M |
AIDXUS20/20 Biolabs | -0.42x | 44.74% | $2.97M |
Risk Warning
Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.
